Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
MiTiHeart is a medical device company specializing in the development of next-generation Left Ventricular Assist Devices (LVADs) for patients with end-stage heart failure. A subsidiary of Mohawk Innovative Technology, Inc., the company leverages proprietary foil bearing and magnetic bearing technologies to create smaller, more durable, and more biocompatible blood pumps. Their flagship product, the MiTiHeart LVAD, is designed to reduce complications such as thrombosis and hemolysis by eliminating the need for traditional mechanical seals and lubricants. The company's mission is to provide a long-term, reliable solution for heart failure patients who are not candidates for transplantation.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on MiTiHeart.